Replies to post #156808 on Vivos Inc (RDGL)

[CatfishHunter]

I tend to concur. Given the proven success already on pets, once we get IDE approval, it won’t take long for the word to really get out about what a gold mine potential Radiogel will be as I expect clinical trials will be very successful and proceed quickly.

[SC8]

Why should we be at ~$0.30/share right now? That was about the peak into BDD speculation, and there's been dilution and more outstanding warrants since. Whatever the peak at IDE approval (gotta submit first), there will have to be an offering to fund human trials, and that will quickly bring price down to earth as offerings do. The fomo momentum buyers don't understand what they're buying, the finances needed and get spooked. C'est la vie.

[den4]

My latest calculation on the human side thus only RadioGel with the current share structure is if they get 1 % of the market in each 18 suggested possible treatments they would be sitting on a 4.5 billion valuation. And then you have IsoPet and the new applications of the hydrogel with could easy double that valuation if not more.

4.5 billion valuation is $12,50 current share structure which by that time offcouse will be totally different